Showing results (1-10 of 154) with videos related to
Sort By:
Pageof 16
Rheumatic Diseases Clinics of North America|August 9, 2005
Raynaud's phenomenon in mixed connective tissue diseaseThomas Grader-Beck, Fredrick M WigleyClinical Reviews in Allergy & Immunology|December 11, 2008
Vascular disease in sclerodermaFredrick M WigleyCurrent Opinion in Immunology|March 4, 2026
Clinical trials and new therapies in Sjögren's diseaseVishal Patel, Antonio Salas, Thomas Grader-BeckRheumatic Diseases Clinics of North America|July 27, 2015
Management of Raynaud Phenomenon and Digital Ulcers in SclerodermaLaura Cappelli, Fredrick M WigleyCurrent Opinion in Rheumatology|October 15, 2005
Understanding, assessing and treating Raynaud's phenomenonFrancesco Boin, Fredrick M WigleyCurrent Opinion in Rheumatology|November 1, 2002
Targeting mediators of vascular injury in sclerodermaLionel Schachna, Fredrick M WigleyCurrent Opinion in Rheumatology|October 6, 2007
Current drug therapy for scleroderma and secondary Raynaud's phenomenon: evidence-based reviewSheridan Henness, Fredrick M WigleyInternational Journal of Clinical Rheumatology|November 3, 2015
Raynaud's phenomenon and digital ischemia: a practical approach to risk stratification, diagnosis and managementZsuzsanna H McMahan, Fredrick M WigleyRheumatic Diseases Clinics of North America|July 5, 2003
Management of Raynaud's phenomenon and digital ischemic lesions in sclerodermaLaura K Hummers, Fredrick M WigleyBest Practice & Research. Clinical Rheumatology|February 3, 2020
Raynaud's phenomenonAriane L Herrick, Fredrick M WigleyPageof 16